Literature DB >> 10975848

Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A.

C H Ricke1, T Staalsoe, K Koram, B D Akanmori, E M Riley, T G Theander, L Hviid.   

Abstract

In areas of intense Plasmodium falciparum transmission, clinical immunity is acquired during childhood, and adults enjoy substantial protection against malaria. An exception to this rule is pregnant women, in whom malaria is both more prevalent and severe than in nonpregnant women. Pregnancy-associated malaria (PAM) in endemic areas is concentrated in the first few pregnancies, indicating that protective immunity to PAM is a function of parity. The placenta is often heavily infected in PAM, and placental parasites show a striking preference for chondroitin sulfate A (CSA) as an adhesion receptor. Plasma Abs from malaria-exposed multiparous women are able to interfere with binding of P. falciparum parasites to CSA in vitro, and acquisition of Abs interfering with CSA-specific parasite sequestration thus appears to be a critical element in acquired protection against PAM. Here we show that adults from an area of hyperendemic P. falciparum transmission generally possessed low levels of Abs specifically recognizing surface Ags expressed by a CSA-adhering parasite isolate, while unselected isolates were well recognized. In marked contrast, most third-trimester pregnant women from that area had very high plasma levels of such Abs. Plasma levels of Abs specifically recognizing the CSA-adhering isolate strongly depended on parity, whereas recognition of CSA-nonadhering isolates did not. Finally, we demonstrate a clear correlation between plasma levels of Abs recognizing the CSA-specific isolate and the ability to interfere with its sequestration to CSA in vitro. Our study supports the hypothesis that Abs inhibiting CSA-specific parasite sequestration are important in acquisition of protection against PAM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10975848     DOI: 10.4049/jimmunol.165.6.3309

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  130 in total

1.  Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of clinically immune pregnant women indicates ongoing placental infection.

Authors:  Michael F Ofori; Trine Staalsoe; Victoria Bam; Maja Lundquist; Kim P David; Edmund N L Browne; Bartholomew D Akanmori; Lars Hviid
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

2.  Molecular basis of severe malaria.

Authors:  Kirk W Deitsch; Chetan E Chitnis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-07       Impact factor: 11.205

3.  Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women.

Authors:  Mirja Hommel; Salenna R Elliott; Viju Soma; Greg Kelly; Freya J I Fowkes; Joanne M Chesson; Michael F Duffy; Joseph Bockhorst; Marion Avril; Ivo Mueller; Andrew Raiko; Danielle I Stanisic; Stephen J Rogerson; Joseph D Smith; James G Beeson
Journal:  Infect Immun       Date:  2010-02-16       Impact factor: 3.441

4.  Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants.

Authors:  Lea Barfod; Tina Dobrilovic; Pamela Magistrado; Pongsak Khunrae; Firmine Viwami; Jonas Bruun; Madeleine Dahlbäck; Nadia L Bernasconi; Michal Fried; Davis John; Patrick E Duffy; Ali Salanti; Antonio Lanzavecchia; Chwee Teck Lim; Nicaise Tuikue Ndam; Matthew K Higgins; Lars Hviid
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

5.  Placental malaria induces variant-specific antibodies of the cytophilic subtypes immunoglobulin G1 (IgG1) and IgG3 that correlate with adhesion inhibitory activity.

Authors:  Salenna R Elliott; Amy K Brennan; James G Beeson; Eyob Tadesse; Malcolm E Molyneux; Graham V Brown; Stephen J Rogerson
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

6.  Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malaria.

Authors:  Lester H Lambert; Jeanee L Bullock; Sharma T Cook; Kazutoyo Miura; David N Garboczi; Mahamadou Diakite; Rick M Fairhurst; Kavita Singh; Carole A Long
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

7.  Variant-specific immunity to Plasmodium berghei in pregnant mice.

Authors:  Rosette Megnekou; Lars Hviid; Trine Staalsoe
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

9.  Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-duffy binding-like 1 alpha domain.

Authors:  Kirsten Moll; Fredrik Pettersson; Anna M Vogt; Cathrine Jonsson; Niloofar Rasti; Sanjay Ahuja; Mats Spångberg; Odile Mercereau-Puijalon; David E Arnot; Mats Wahlgren; Qijun Chen
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

10.  Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya.

Authors:  Steven D Perrault; Jan Hajek; Kathleen Zhong; Simon O Owino; Moses Sichangi; Geoffrey Smith; Ya Ping Shi; Julie M Moore; Kevin C Kain
Journal:  Am J Trop Med Hyg       Date:  2009-01       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.